Full text is available at the source.
Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats
Ganoderma lucidum polysaccharides may restore gut bacteria and metabolism in type 2 diabetic rats
AI simplified
Abstract
Administration of Ganoderma lucidum polysaccharides (GLP) resulted in significant decreases in fasting blood glucose and insulin levels in type 2 diabetes mellitus (T2DM) rats.
- GLP treatment reduced the abundance of harmful bacteria, including Aerococcus and Ruminococcus.
- In contrast, GLP increased beneficial bacteria such as Blautia and Bacteroides.
- GLP may restore disrupted metabolism of amino acids, carbohydrates, inflammatory substances, and nucleic acids in the gut microbiota.
- Metabolomic analysis showed that metabolic changes aligned with the effects of GLP on gut bacteria.
AI simplified